Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;21(6):625-632.
doi: 10.4196/kjpp.2017.21.6.625. Epub 2017 Oct 30.

MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation

Affiliations

MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation

Seongmi Lee et al. Korean J Physiol Pharmacol. 2017 Nov.

Abstract

Familial Parkinson's disease (PD) has been linked to point mutations and duplication of the α-synuclein (α-syn) gene. Mutant α-syn expression increases the vulnerability of neurons to exogenous insults. In this study, we developed a new PD model in the transgenic mice expressing mutant hemizygous (hemi) or homozygous (homo) A53T α-synuclein (α-syn Tg) and their wildtype (WT) littermates by treatment with sub-toxic (10 mg/kg, i.p., daily for 5 days) or toxic (30 mg/kg, i.p., daily for 5 days) dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Tyrosine hydroxylase and Bcl-2 levels were reduced in the α-syn Tg but not WT mice by sub-toxic MPTP injection. In the adhesive removal test, time to remove paper was significantly increased only in the homo α-syn Tg mice. In the challenging beam test, the hemi and homo α-syn Tg mice spent significantly longer time to traverse as compared to that of WT group. In order to find out responsible proteins related with vulnerability of mutant α-syn expressed neurons, DJ-1 and ubiquitin enzyme expressions were examined. In the SN, DJ-1 and ubiquitin conjugating enzyme, UBE2N, levels were significantly decreased in the α-syn Tg mice. Moreover, A53T α-syn overexpression decreased DJ-1 expression in SH-SY5Y cells. These findings suggest that the vulnerability to oxidative injury such as MPTP of A53T α-syn mice can be explained by downregulation of DJ-1.

Keywords: Apoptosis; DJ-1; MPTP; Parkinson's disease; Synuclein.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1. Evaluation of synaptophysin and synuclein expression in the SN of WT and α-syn Tg mice.
(A) SN tissue lysates were immunoblotted with each antibody. (B, C) The intensity of each band was normalized to that of β-actin and presented in bar graphs. The values represent the means±SD (n=7). *p<0.05, **p<0.01.
Fig. 2
Fig. 2. Evaluation of TH expression in the SN of MPTP-treated Tg mice.
Mice were treated with MPTP for 5 days. (A) SN tissue lysates were immunoblotted with each antibody. The intensity of each band was normalized to that of β-actin and presented in bar graphs. (B) Immunostaining of TH was evaluated in the SN of MPTP-treated Hemi Tg mice. The number of TH-positive cells in the SN is shown in bar graphs (right panel). (Bar, 200 µm) The values represent the means±SD (n=7). *p<0.05, **p<0.01.
Fig. 3
Fig. 3. Evaluation of Bcl-2 expression in the SN of control and MPTP-treated mice.
Mice were treated with MPTP for 5 days. (A) SN tissue lysates were immunoblotted with each antibody. (B) The intensity of each band was normalized to that of β-actin and presented in bar graphs. The values represent the means±SD (n=7). *p<0.05, **p<0.01.
Fig. 4
Fig. 4. Behavioral tests of MPTP-treated Tg mice.
Mice were treated with MPTP for 5 days. Adhesive removal test (A) and challenging beam traversal test (B) were performed at day 12. The values represent the means±SD (n=7). *p<0.05 vs WT, **p<0.01 vs WT, p<0.05 vs Hemi, p<0.05 vs Home.
Fig. 5
Fig. 5. Evaluation of DJ-1 and UBE2N expression in the SN of WT and α-syn Tg mice.
(A) SN tissue lysates were immunoblotted with each antibody. (B) The intensity of each band was normalized to that of β-actin and presented in bar graphs. The values represent the means±SD (n=7). *p<0.05 vs. WT.
Fig. 6
Fig. 6. Reduced cell viability and DJ-1 down-regulation in the A53T synuclein overexpressed SH-SY5Y cells.
(A) SH-SY5Y cells were infected with A53T synuclein lentivirus for 72 h and the cells were treated with various concentration of 6-OHDA for 24 h. The expression level of synuclein was examined by immunoblotting (upper panel). Then, cell viability was examined by MTT assay. (B) SH-SY5Y cells were infected with 1, 5, or 10 m.o.i. of A53T synuclein lentivirus for 72 h and the cell lysates were electrophoresed and immunoblotted with indicated antibody. The intensity of each band was normalized to that of β-actin and presented in bar graphs. (C) SH-SY5Y cells were transfected with control or DJ-1 siRNA for 48 h. Then, cell viability was examined by MTT assay cells and DJ-1 expression was examined by immunoblotting. The values represent the means±SD (n=4). **p<0.01 vs. Control. ***p<0.001 vs. Control.

Similar articles

Cited by

References

    1. Habibi E, Masoudi-Nejad A, Abdolmaleky HM, Haggarty SJ. Emerging roles of epigenetic mechanisms in Parkinson's disease. Funct Integr Genomics. 2011;11:523–537. - PubMed
    1. Jenner P, Olanow CW. Understanding cell death in Parkinson's disease. Ann Neurol. 1998;44(3 Suppl 1):S72–S84. - PubMed
    1. de Silva HR, Khan NL, Wood NW. The genetics of Parkinson's disease. Curr Opin Genet Dev. 2000;10:292–298. - PubMed
    1. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995;14:467–475. - PubMed
    1. Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, Przuntek H, Epplen JT, Schöls L, Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998;18:106–108. - PubMed